News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Antero Resources expects materially higher free cash flow in H2 2026.
  • Shares trade around $34.92, implying a steep discount to historical cyclic peaks.
  • Debt/equity stands near 0.31, reducing leverage risk.
  • EV/EBITDA sits near 6, pointing to a cheap valuation.
  • Report outlines entry, stop and target for a 180 trading-day horizon.

Latest Articles

AbbVie Shares Slide After Q2 Results, Guidance Miss Sparks Profit-Taking

AbbVie Shares Slide After Q2 Results, Guidance Miss Sparks Profit-Taking

AbbVie shares fell sharply in pre-market trading after the company released second-quarter 2026 results and reiterated guidance that came in below Wall Street expectations. A previously disclosed $291 million IPR&D and milestones charge that trims EPS by $0.17 per share, combined with adjusted Q2 EPS guidance beneath consensus, prompted a class…

Eaton Stock Jumps After Strong Q2 Results and Upbeat Q3 Guidance

Eaton Stock Jumps After Strong Q2 Results and Upbeat Q3 Guidance

Eaton Corporation PLC rallied in pre-market trade after reporting second-quarter 2026 results that outpaced analyst forecasts on both earnings and revenue, and after issuing third-quarter adjusted EPS guidance above consensus. Management’s continued pattern of conservative targets, ongoing portfolio changes, and broad market strength combined to pu…

Clariant Shares Rise as Q2 Results Outperform and Major Lawsuit Dismissed

Clariant Shares Rise as Q2 Results Outperform and Major Lawsuit Dismissed

Clariant AG shares climbed after the company reported second-quarter results that exceeded analyst forecasts, coupled with a court ruling that dismissed a sizeable damages claim. The combination of stronger-than-expected adjusted EBITDA and sales, higher cost-savings targets and above-target free cash flow underpinned investor confidence and lifted…

Buying Optionality: A Speculative Swing Trade on Innate Pharma (IPHA)

Buying Optionality: A Speculative Swing Trade on Innate Pharma (IPHA)

Innate Pharma (IPHA) trades at roughly $168M market cap with multiple clinical-stage assets in oncology. The shares sit near $1.75 after pulling back from a $2.62 52-week high; average volumes are low and short interest has been meaningful. For traders willing to accept binary clinical and financing risk, a controlled long swing (mid term, 45 tradi…

AI Spending Spurs Tech Rally as Apple Guidance Pressures Shares Premarket

AI Spending Spurs Tech Rally as Apple Guidance Pressures Shares Premarket

U.S. equity futures rose as investor optimism around artificial intelligence spending strengthened demand for technology and semiconductor stocks following a robust cloud update from Amazon. Major movers included Amazon, which jumped after reporting its strongest cloud revenue growth in over four years and disclosing a $25 billion annual run rate f…

Rocket Lab Gains After New iQPS Launch Contract and Pre-Earnings Optimism

Rocket Lab Gains After New iQPS Launch Contract and Pre-Earnings Optimism

Rocket Lab shares advanced in pre-market trading after the company signed a third consecutive multi-launch agreement with Japanese synthetic aperture radar operator iQPS for three more dedicated Electron launches. The deal raises iQPS's total Electron missions to 18 and comes as analysts maintain bullish ratings and investors position ahead of Rock…

U.S. Equity Funds Return to Net Inflows as Mega-Cap Tech Lures Buyers

U.S. Equity Funds Return to Net Inflows as Mega-Cap Tech Lures Buyers

U.S. equity mutual funds and ETFs recorded net inflows in the week through July 29, driven by renewed interest in mega-cap technology names following robust earnings from Microsoft and Amazon. The $11.83 billion of net purchases into U.S. equities more than offset the $10.68 billion pulled over the prior two weeks, while flows into bond funds slowe…

Cboe Earnings Soar as Volatility Fuels Options Volume Boom

Cboe Earnings Soar as Volatility Fuels Options Volume Boom

Cboe Global Markets posted a sizable second-quarter profit increase driven by a surge in options trading amid elevated market volatility. The firm recorded strong growth in options revenue and overall net revenue, supported by record U.S. options volumes and a single-day contract peak during a sharp market sell-off. Cboe's market position in retail…

Dragonfly Energy Announces Strategic Acquisition of Dakota Lithium Assets, Expanding Into New Markets

Dragonfly Energy Announces Strategic Acquisition of Dakota Lithium Assets, Expanding Into New Markets

Dragonfly Energy Holdings Corp. announced the acquisition of substantially all operating assets of Dakota Lithium, expanding its presence in marine, outdoor recreation, powersports, and other specialty battery markets. With Dakota Lithium generating approximately $12 million in net revenue in 2025 despite product availability constraints, Dragonfly…

Medicus Pharma Receives UAE Department of Health (DOH) Authorization to proceed with Novel Prospective Genomics Guided Precision Medicine Study Evaluating Teverelix® in Women with Endometriosis

Medicus Pharma Receives UAE Department of Health (DOH) Authorization to proceed with Novel Prospective Genomics Guided Precision Medicine Study Evaluating Teverelix® in Women with Endometriosis

Medicus Pharma announced that the UAE Department of Health has granted Investigational New Drug authorization for the PRECISION-E2 Phase 2a study evaluating Teverelix® in women with moderate-to-severe endometriosis. This study is a pioneering genomics-guided precision medicine trial aiming to optimize treatment by integrating genetic, pharmacologic…

YXT.com Regains Compliance with Nasdaq Minimum Bid Price Requirement

YXT.com Regains Compliance with Nasdaq Minimum Bid Price Requirement

YXT.com Group Holding Limited has successfully regained compliance with Nasdaq's minimum bid price requirement by increasing its ADS ratio from 1:3 to 1:30, resulting in the ADS closing price meeting or exceeding $1.00 for 10 consecutive business days. This reinstates the company’s standing on the Nasdaq exchange after earlier notices of non-compli…

Nextpower Soars in Pre-Market After Far Exceeding Q1 Fiscal 2027 Forecasts

Nextpower Soars in Pre-Market After Far Exceeding Q1 Fiscal 2027 Forecasts

Nextpower surged in pre-open trading after reporting first-quarter fiscal 2027 results that substantially beat Wall Street expectations. Adjusted EPS and revenue topped forecasts by wide margins, while gross margins expanded and backlog surpassed $5.5 billion. The company also closed an acquisition to strengthen inverter capabilities and retains a …

Newell Brands Shares Spike After Quarterly Beat and Raised Outlook

Newell Brands Shares Spike After Quarterly Beat and Raised Outlook

Newell Brands stock climbed 15.7% in pre-market trading after the company reported second-quarter 2026 adjusted EPS of $0.42, more than double the Wall Street consensus of $0.19, and revenue of $2.0 billion, slightly above expectations. A $126 million pretax tariff recovery and a marked upgrade to full-year guidance helped drive the move, alongside…

Cohu Shares Jump After Strong Q2 Beat and Upgraded HPC Guidance

Cohu Shares Jump After Strong Q2 Beat and Upgraded HPC Guidance

Cohu's stock spiked in pre-market trading after the semiconductor test equipment maker reported a sizable beat on second-quarter 2026 earnings and revenue, raised its HPC revenue outlook for the year, and issued Q3 guidance implying strong year-over-year growth. Analysts raised price targets and the broader market's positive tone helped lift invest…